Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients
出版年份 2014 全文链接
标题
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients
作者
关键词
Cryocare cryoablation, Carbohydrate antigen, Carcinoembryonic antigen, Tumor-specific growth factor, Pancreatic cancer
出版物
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 71, Issue 3, Pages 1287-1291
出版商
Springer Nature
发表日期
2014-12-08
DOI
10.1007/s12013-014-0345-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Differentially Expressed miRNAs in Cancer-Stem-Like Cells: Markers for Tumor Cell Aggressiveness of Pancreatic Cancer
- (2014) Bin Bao et al. STEM CELLS AND DEVELOPMENT
- Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer
- (2014) Xueyan Li et al. TUMOR BIOLOGY
- Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis
- (2014) Zhe Huang et al. TUMOR BIOLOGY
- Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer
- (2014) Jian-Guo Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis
- (2013) Ji-Cong Gui et al. CLINICAL AND EXPERIMENTAL MEDICINE
- The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients
- (2013) Mitsuro Kanda et al. SURGERY TODAY
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
- (2013) Uwe Pelzer et al. Frontiers in Oncology
- Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients
- (2012) Gang Zhou et al. BIOTECHNOLOGY LETTERS
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study
- (2012) Jeffrey M. Vainshtein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice
- (2012) Sukhwinder Kaur et al. PANCREAS
- The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
- (2011) Sundeep Singh et al. DIGESTIVE DISEASES AND SCIENCES
- Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer
- (2011) Tae Yoo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now